• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Nanoform, Aprecia Partner to Advance 3DP Nanomedicines

    KemPharm Receives $10M Milestone for FDA Approval of Azstarys

    Valneva Focuses on Bilateral Discussions to Supply COVID-19 Vax

    Syneos, Medable Partner for New Decentralized Capabilities

    CSafe Global Appoints SVP of Technology and Innovation
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Evotec to Build Second Biologics Mfg. Facility in Toulouse

    Abenza Chooses North Carolina for New Biologics Manufacturing Site

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Recro, Ensysce Expand Development and Manufacturing Partnership

    Metrics Names Stephanie Emory Associate Director of Pharma Development
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    TraceLink Introduces Opus Platform

    Obituary Notice: Russell “Russ” Haines

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Nanoform, Aprecia Partner to Advance 3DP Nanomedicines

    KemPharm Receives $10M Milestone for FDA Approval of Azstarys

    Valneva Focuses on Bilateral Discussions to Supply COVID-19 Vax

    Syneos, Medable Partner for New Decentralized Capabilities

    Valneva’s Inactivated, Adjuvanted COVID-19 Vax Achieves Positive Data
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Unifying Quality Manufacturing to Drive Speed, Collaboration, and Compliance

    Ensuring Pharma Manufacturing Quality

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Alcami

    Adare Pharma Solutions

    Baxter BioPharma Solutions

    Aphena Pharma Solutions

    Almac Group
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    PCI Pharma Services

    Quotient Sciences

    Adare Pharma Solutions

    Almac Group

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    HPAPI Market Trends: PCI Expands Capabilities

    Michael Ellingson of PCI discusses market demand for specialty drug product capabilities and the Rockford, IL expansion

    HPAPI Market Trends: PCI Expands Capabilities
    Related CONTENT
    • Sterling Pharma Solutions Acquires ADC Biotechnology
    • Outsourcing Solid Dosage Manufacturing
    • Arcline Investment Acquires ChargePoint Technology
    • Parenteral Drug Delivery Trends
    • Chemical Development
    Kristin Brooks, Cotract Pharma01.10.20
    The growth in targeted therapies for oncology indications is driving demand for highly potent active pharmaceutical ingredients (HPAPIs). For the most part these are small molecule cytotoxic compounds and antibody drug conjugates (ADCs) for cancer indications. Additional therapeutic areas in the HPAPI space include respiratory, hormonal, cardiovascular, and central nervous system disorders, among others.
     
    With more than 20 new oncology therapies launched in the past two years it’s an area that continues to grow for pharmaceutical manufacturers and CMOs. According to MarketWatch, the HPAPI market is expected to exceed more than $28.0 billion by 2024 at a CAGR of 8.5%.
     
    Due to the high level of toxicity, manufacturers must have the appropriate controls, safety equipment, and risk management processes in place to ensure a safe handling and adhere to strict regulatory requirements. Many pharma and biopharma companies opt to outsource to contract manufacturers with the necessary expertise and capabilities to handle highly potent substances.
     
    PCI Pharma Services recently completed an expansion of its Rockford, IL facility to enhance its specialty drug product capabilities. The 30,000 sq.-ft. facility dedicated to specialty drug products now includes four high potent compound capable suites built to ISO8 standards. PCI also built three new secondary packaging areas to deliver increased scalability and installed three new coolers and a new freezer for -20°C to -8°C cold chain requirements.
     
    Contract Pharma spoke with Michael Ellingson, Operations Director, Specialty at PCI Pharma Services about the growth of high potency APIs and the specialized manufacturing capabilities needed to handle them. –KB
     
    Contract Pharma: What special requirements and capabilities are needed for high potent compounds?
     
    Michael Ellingson: The demand for Highly Potent Active Pharmaceutical Ingredients (HPAPI) continues to grow with oncology drugs accounting for nearly 40% of the global clinical pipeline. As we are seeing an increased demand for HPAPI handling, we are focusing on improving our capacity and capabilities to meet customer requirements. To meet these goals, we recently finished the expansion of our existing Rockford, IL facility, which included high potent compound capable suites that are built to IS08 standards. These suites act as a containment measure achieved through negative and positive pressure, and heightened air filtering.  
     
    Our teams also work to meet strict regulatory requirements, such as cross-contamination controls, and reliable reproducibility through geometric scale-up. Our facility in Tredegar, South Wales also meets these requirements and we’ve started an expansion at this facility to further support business growth and we expect this new space to be operational in the first half of 2022. 
     
    CP: In what therapeutic areas do you see the most growth?
     
    ME: As we continue to see an increase in innovation and research across the oncology ecosystem, there begins to be a stronger need for high potent compounds to support these advancements. Active compounds in oncology research and development has quadrupled since 1996 and doubled since 2008. PCI Pharma Services has supported this growth and has simultaneously seen demands for our services and partnerships increase. We work with our clients from early stage development to long term commercial supply. Staggering growth in oncology R&D presents an opportunity for PCI to increase our manufacturing capabilities and packaging capabilities. We aim to provide services and a supply chain from start to finish – from drug development to commercialization – and as oncology drugs are continuing to be developed, we work with our clients to provide solutions to challenges to ultimately deliver life-changing treatments to patients.
     
    CP: From what pharma/biopharma sector do you see the most demand?
     
    ME: We have seen consistent growth in oncology products, along with high potent compounds and products to treat specific food allergens. The industry has seen a significant shift in the ability of small and mid-size pharmaceutical companies to bring projects to the finish line of commercialization.
     
    Although we continue to see growth in big pharmaceutical companies, the growth rate in small and mid-size companies is outpacing that of their larger peers in the space. As such, PCI has added to our service offerings with clinical support, packaging options and program management skills in the end-to-end commercialization process as to provide start to finish support for customers. For obvious reasons, this support tends to be most critical for smaller, often less experienced, startup customers.



     
    Michael is the Director of Specialty Operations where he focuses on driving process improvements and oversees operational excellence. Prior to his current role, Michael held key positions across PCI’s project management and operations teams. In addition to his responsibilities at PCI, Mike is the site SME for a recent S&OP implementation project where he manages all scheduling, forecasting, capacity analyses and labor management for the Rockford Commercial sites.
    Related Searches
    • packaging
    • pipeline
    • it
    • Development
    Suggested For You
    Sterling Pharma Solutions Acquires ADC Biotechnology Sterling Pharma Solutions Acquires ADC Biotechnology
    Outsourcing Solid Dosage Manufacturing Outsourcing Solid Dosage Manufacturing
    Arcline Investment Acquires ChargePoint Technology Arcline Investment Acquires ChargePoint Technology
    Parenteral Drug Delivery Trends Parenteral Drug Delivery Trends
    Chemical Development Chemical Development
    Commercial Manufacturing Commercial Manufacturing
    Inhalation CDMO Vectura Expands HPAPI Capabilities Inhalation CDMO Vectura Expands HPAPI Capabilities
    Legacy Pharma Solutions Legacy Pharma Solutions
    PCI Pharma Services PCI Pharma Services
    Catalent Pharma Solutions Catalent Pharma Solutions
    Lonza Expands HPAPI Capabilities Lonza Expands HPAPI Capabilities
    Regis Custom Pharma Regis Custom Pharma
    Emphasizing Sustainability in Contract Manufacturing Emphasizing Sustainability in Contract Manufacturing
    MilliporeSigma Expands HPAPI and ADC Mfg. Capabilities MilliporeSigma Expands HPAPI and ADC Mfg. Capabilities
    Seqens Opens New HPAPI Unit Seqens Opens New HPAPI Unit

    Related Online Exclusives

    • cGMP Manufacture | QA/QC
      Ensuring Pharma Manufacturing Quality

      Ensuring Pharma Manufacturing Quality

      How today’s life sciences manufacturers can effectively monitor processes, integrate with sub-contractors and align with regulatory reporting requirements.
      Kristin Brooks, Contract Pharma 04.14.21

    • Clinical Trials | Drug Development | QA/QC
      RBQM Comes of Age: COVID as a Catalyst for Change

      RBQM Comes of Age: COVID as a Catalyst for Change

      Clinical trial conduct has undergone a fundamental shift over the last year – and things will never be the same again.
      Kristin Brooks, Managing Editor 04.01.21

    • Biologics, Proteins, Vaccines | cGMP Manufacture
      Advanced Analytics Advancing Development of Genetic Vaccines

      Advanced Analytics Advancing Development of Genetic Vaccines

      Leveraging innovative advanced analytical technologies to ensure regulatory compliance in the development and production of novel vaccines.
      Kristin Brooks, Managing Editor, Contract Pharma 03.29.21


    • Cytotoxics and High Potency Manufacturing | Facilities | Solid Dosage/Creams/Ointments
      Outsourcing Solid Dosage Manufacturing

      Outsourcing Solid Dosage Manufacturing

      A Q&A with Dan Dobry, head of drug product commercial development at Lonza Pharma & Biotech.
      Tim Wright, Editor, Contract Pharma 03.12.21

    • Cold Chain Management | Logistics | Packaging & Tracking | Supply Chain
      Reshaping the Pharmaceutical Supply Chain

      Reshaping the Pharmaceutical Supply Chain

      The pandemic and COVID-19 vaccines bring navigating the cold-chain and preserving precious biologics to the forefront.
      Kristin Brooks, Managing Editor 03.01.21

    • Solid Dosage/Creams/Ointments
      Solid Dose Market Trends

      Solid Dose Market Trends

      A Q&A with Mark DaFonseca, chief business officer at CoreRx.
      Tim Wright, Editor, Contract Pharma 02.26.21


    • Drug Delivery
      Aerosol Delivery Devices Market

      Aerosol Delivery Devices Market

      Advantages over conventional drug delivery devices, rise in prevalence of COPD and asthma drive the growth of the global aerosol delivery devices market.
      Allied Market Research 02.16.21

    • Biologics, Proteins, Vaccines | Clinical Trials
      Inside a COVID Vaccine Trial

      Inside a COVID Vaccine Trial

      Dr. Murphy of ICON, provider of clinical services to Pfizer/BioNTech’s COVID vaccine program, discusses what it takes to conduct a vaccine trial of this scale.
      Kristin Brooks, Managing Editor 02.05.21

    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development
      The Future of Vaccines and Biologics

      The Future of Vaccines and Biologics

      Dr. Linda Marbán of Capricor Therapeutics discusses the advances in responding to infectious diseases.
      Kristin Brooks, Managing Editor, Contract Pharma 02.04.21


    • Clinical Trials | Information Technology
      The State of Clinical Trial Technology

      The State of Clinical Trial Technology

      Blake Adams of Florence discusses key report findings and the clinical trial software used to support Pfizer’s global COVID-19 vaccine study.
      Kristin Brooks, Contract Pharma 01.26.21

    • Analytical Services | Laboratory Testing
      Improving Product Profitability

      Improving Product Profitability

      Using PAT/QbD/CM as tools to increase profitability of products.
      Emil Ciurczak, Contributing Editor 01.21.21

    • Analytical Services | Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Fill/Finish
      A New Era of Vaccine and Biologic Drug Development

      A New Era of Vaccine and Biologic Drug Development

      As a result of COVID-19, unprecedented investments in vaccines, diagnostics, and treatments have had a tremendous impact on the Biotechnology industry.
      Kristin Brooks, Managing Editor 01.12.21


    • Clinical Trials | Drug Development | Information Technology
      Advancing Digital Endpoints in Clinical Trials

      Advancing Digital Endpoints in Clinical Trials

      An end-to-end approach to managing wearable devices through clinical development.
      Kristin Brooks, Contract Pharma 12.14.20

    • Drug Delivery | Drug Development
      Inhaled Drug Delivery Technology Trends

      Inhaled Drug Delivery Technology Trends

      The success of new inhaled medicines relies on the correct combination of formulation and device technology.
      Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura 11.24.20

    • Bioanalytical Services | cGMP Manufacture | Drug Development | Scale-up/Technology Transfer
      CDMOs: Keeping up with Science & Technology

      CDMOs: Keeping up with Science & Technology

      Enhancing the development of increasingly advanced and complex drug candidates is needed to drive growth in the industry.
      Kristin Brooks, Contract Pharma 11.12.20

    Trending
    • Franco Negron Named CEO Of ApiJect Systems America
    • Obituary Notice: Russell “Russ” Haines
    • Resilience Acquires Ology Bioservices
    • Valneva Focuses On Bilateral Discussions To Supply COVID-19 Vax
    • Johnson & Johnson 1Q Results
    Breaking News
    • Nanoform, Aprecia Partner to Advance 3DP Nanomedicines
    • KemPharm Receives $10M Milestone for FDA Approval of Azstarys
    • Valneva Focuses on Bilateral Discussions to Supply COVID-19 Vax
    • Syneos, Medable Partner for New Decentralized Capabilities
    • CSafe Global Appoints SVP of Technology and Innovation
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Ashland Supports the Nature Conservancy Forest Restoration Effort to Help Plant a Billion Trees
    Martin Bauer Announces Installation of Agile Filling System at Bethlehem, PA Facility
    PepsiCo and Ingredion Begin Pilot Partnership with Soil and Water Outcomes Fund
    Coatings World

    Latest Breaking News From Coatings World

    AkzoNobel Shareholders Approve Final Dividend at Annual General Meeting
    PPG Maintains EcoVadis Gold Rating
    Sustainable Plastics Will Make Up More Than 15% of Production by 2030
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Getinge Receives FDA Clearance for Multiple Products
    Study Shows Benefits of CCHD Screening Using Masimo SET Pulse Oximetry
    TEAM Technologies Acquires ViruDefense
    Contract Pharma

    Latest Breaking News From Contract Pharma

    RDIF, Minapharm to Make Over 40M Doses of the Sputnik V Vaccine in Egypt
    Bora Pharmaceuticals Completes Health Canada Inspection
    Nanoform, Aprecia Partner to Advance 3DP Nanomedicines
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Johnson & Johnson Reports Sales Increase in First Quarter of 2021
    THG Launches Recycling Program in UK
    Knoll Printing & Packaging Commits to a Healthy Ocean and Planet
    Happi

    Latest Breaking News From Happi

    L’Oréal Successfully Defends Itself In Patent Infringement Lawsuit
    TFF Names 2021 Honorees for Lifetime Achievement Perfumer and Hall of Fame
    Ashland Donates $20,000 To Help Plant Trees
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    SE-DA Invests in Kornit Presto S
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Ashland commits to forest restoration
    Epson upgrades SurePress demo facility
    Xeikon helps converters navigate toner and inkjet
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Savaré Strengthens Technical Support for the Americas
    FiberVisions, Avgol Partner with Polymateria
    High-Tech Conversions Launches Wipes Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA Clears Orthofix's 3D-Printed FORZA Titanium TLIF Spacer System
    Patients Conclude Clinical Visits in Knee Osteoarthritis Treatment Study
    SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Identiv, Ameta International Announce US, Canadian Distribution Partnership
    Adesis Achieves ISO 9001:2015 Certification
    Louis Widmer SA Complies with EU Anti-Counterfeiting Directive with Zebra Technologies’ Solution

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login